TrialMedical oncology (Northwood, London, England)2012

A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.

Sheng Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.